Vaughn D. Bryson

Vaughn D. Bryson is a declared insider at 5 companies; the most frequent names are Atherogenics Inc, Chiron Corp and Amylin Pharmaceuticals Inc. Between 30 December 2005 and 18 May 2011, the trades on record add up to 23 filings.

Both buying and selling appear: 7 purchases worth €1.1M, against 7 sales worth €111k. Purchases outweigh sales by €961k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 4 share grants.

Half of the purchases are above €175k and half below.

On 6 December 2011 came the latest disclosure, a transaction for €27k in Pharmaceutical Product Development Inc. The most recent open-market purchase was published on 7 April 2008, 6,773 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.